Cover ImageSALE
市場調查報告書

醫藥品受託製造的全球市場:2016∼2020年

Global Pharmaceutical Contract Manufacturing Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 387464
出版日期 內容資訊 英文 81 Pages
訂單完成後即時交付
價格
Back to Top
醫藥品受託製造的全球市場:2016∼2020年 Global Pharmaceutical Contract Manufacturing Market 2016-2020
出版日期: 2016年11月02日 內容資訊: 英文 81 Pages
簡介

全球醫藥品受託製造市場預計從2016年到2020年以6.91%的年複合成長率擴大。醫藥品受託製造,在印度和中國等的新興國家中有很大的成長機會。

本報告提供全球醫藥品受託製造市場相關調查,至2020年的成長預測,供應商趨勢,各地區趨勢,及加入此市場的主要供應商簡介等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 醫藥品製造的外包

  • 法律規章指南與醫療費抑制策略
  • 迅速的技術創新與產品開發生命週期的縮短
  • 巨額的設備投資

第6章 市場情況

  • 市場概要
  • 波特的五力分析

第7章 各類型市場區隔

  • API/膨脹劑
  • FDF

第8章 各地區市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第9章 主要國家

第10章 市場趨勢

  • 對核心競爭力的關注高漲
  • 新興國家中美國FDA認證的製造設施多
  • 縮短到上市為止的時間

第11章 促進要素的影響

第12章 市場課題

  • 能力利用問題與資訊整合的不足
  • 全球的競爭激烈
  • 製造標準化的不足

第13章 促進要素與課題的影響

第14章 市場趨勢

第15章 供應商環境

  • 競爭模式

第16章 主要供應商分析

  • Catalent
  • Lonza
  • Pfizer CentreOne
  • 其他值得注意的供應商

第17章 附錄

第18章 關於Technavio

目錄
Product Code: IRTNTR10393

About Pharmaceutical Contract Manufacturing

Contract manufacturing involves outsourcing manufacturing products to organizations, which helps the organizations offer the same services at a relatively lower cost. Typically, in the pharmaceutical and biotechnology sectors, the sourcing companies seek contract manufacturing services to restructure their resource deployment toward high skill areas such as R&D and marketing. Contract manufacturing has potential growth opportunities in emerging countries such as India and China.

Technavio's analysts forecast the global pharmaceutical contract manufacturing market to grow at a CAGR of 6.91% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global pharmaceutical contract manufacturing market for 2016-2020. To calculate the market size, the report considers the revenue generated from various pharmaceutical drug manufacturing outsourcing activities.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Pharmaceutical Contract Manufacturing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Catalent
  • Lonza
  • Pfizer CentreOne

Other Prominent Vendors

  • Abbott
  • Aenova
  • Amgen
  • Apotex
  • Aspen
  • AstraZeneca
  • Aurobindo Pharma
  • Baxter
  • BERLIN-CHEMIE
  • Biocon
  • Biogen
  • Boehringer Ingelheim
  • Celltrion
  • Cipla
  • Coherus Biosciences
  • Daiichi Sankyo
  • Dr. Reddy's Laboratories
  • Eli Lilly
  • Emcure Pharmaceuticals
  • Eurofarma Laboratories
  • Fareva
  • Gedeon Richter
  • Gilead Sciences
  • GlaxoSmithKline (GSK)
  • Hospira
  • Impax Laboratories
  • Intas Pharmaceuticals
  • Janssen Pharmaceuticals
  • Lupin
  • Merck
  • Mitsubishi Tanabe Pharma
  • Momenta Pharmaceuticals
  • Natco Pharma
  • Nexus Pharmaceuticals
  • Novo Nordisk
  • Orchid Chemicals & Pharmaceuticals
  • Par Pharmaceutical
  • Parenteral Drugs India
  • Patheon
  • Piramal
  • Roche Holding
  • Sanofi
  • Synthon
  • Teva Pharmaceuticals
  • Valeant Pharmaceuticals
  • Zentiva
  • Zhejiang Huahai Pharmaceutical
  • Zydus Cadila

Market driver

  • High number of US FDA-approved manufacturing facilities in emerging countries.
  • For a full, detailed list, view our report

Market challenge

  • Capacity utilization issues and lack of information integration.
  • For a full, detailed list, view our report

Market trend

  • Huge demand for next-generation biologics.
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Pharmaceutical manufacturing outsourcing

  • Increased regulatory guidelines coupled with healthcare cost containment efforts
  • Rapid innovation and reduced product development lifecycle
  • High capital investment

PART 06: Market landscape

  • Market overview
  • Five forces analysis

PART 07: Market segmentation by type of contract manufacturing

  • Global API/bulk drug contract manufacturing market
  • Global FDF market

PART 08: Geographical segmentation

  • Global pharmaceutical contract manufacturing market by geography
  • Pharmaceutical contract manufacturing market in Americas
  • Pharmaceutical contract manufacturing market in APAC
  • Pharmaceutical contract manufacturing market in EMEA

PART 09: Key leading countries

PART 10: Market drivers

  • Increased focus on core competence
  • High number of US FDA-approved manufacturing facilities in emerging countries
  • Shorter time-to-market

PART 11: Impact of drivers

PART 12: Market challenges

  • Capacity utilization issues and lack of information integration
  • Growing global competition
  • Lack of manufacturing standardization

PART 13: Impact of drivers and challenges

PART 14: Market trends

  • Consolidation through vertical integration, alliances, and acquisitions
  • Huge demand for next-generation biologics
  • Value-added services

PART 15: Vendor landscape

  • Competitive scenario

PART 16: Key vendor analysis

  • Catalent
  • Lonza
  • Pfizer CentreOne
  • Other prominent vendors

PART 17: Appendix

  • List of abbreviations

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Service offerings
  • Exhibit 02: Overview of global pharmaceutical contract manufacturing market
  • Exhibit 03: Global pharmaceutical contract manufacturing market: Present and future scenario
  • Exhibit 04: Process of drug development
  • Exhibit 05: Value chain of pharmaceutical industry
  • Exhibit 06: Contract manufacturing market: Benefit analysis
  • Exhibit 07: Factors affecting pharmaceutical manufacturing outsourcing
  • Exhibit 08: Key factors and its impact on selection of CMOs
  • Exhibit 09: Global pharmaceutical contract manufacturing market: Market overview
  • Exhibit 10: CMO market growth
  • Exhibit 11: Overview of outsourced new drug abbreviations (NDAs) in CMO industry
  • Exhibit 12: Cost comparison of drug development in the US and India
  • Exhibit 13: Global pharmaceutical contract manufacturing market 2015-2020 ($ billions)
  • Exhibit 14: Average number of services outsourced by company type 2013-2015
  • Exhibit 15: Preference for choosing pharmaceutical outsourcing partners
  • Exhibit 16: Factors affecting the global pharmaceutical contract manufacturing market
  • Exhibit 17: Opportunities analysis: Global pharmaceutical contract manufacturing market
  • Exhibit 18: Growth of global pharmaceutical contract manufacturing market 2016-2020
  • Exhibit 19: Five forces analysis
  • Exhibit 20: Market segmentation based on type of contract manufacturing
  • Exhibit 21: Segment outlook
  • Exhibit 22: Market overview of global API/bulk drug manufacturing market
  • Exhibit 23: Global API/bulk drug contract manufacturing market 2015-2020 ($ billions)
  • Exhibit 24: Global API/bulk drug contract manufacturing market
  • Exhibit 25: Overview of API outsourcing manufacturing market
  • Exhibit 26: Market share of global FDF market 2015
  • Exhibit 27: Types of dosage forms
  • Exhibit 28: Lifecycle analysis of dosage formulations
  • Exhibit 29: Global FDF market 2015-2020 ($ billions)
  • Exhibit 30: Market share of global pharmaceutical contract manufacturing market 2015
  • Exhibit 31: Global pharmaceutical contract manufacturing market: Geography outlook 2015-2020
  • Exhibit 32: Global pharmaceutical contract manufacturing market: Current and future impact
  • Exhibit 33: Pharmaceutical contract manufacturing market in Americas 2015-2020 ($ billions)
  • Exhibit 34: Pharmaceutical contract manufacturing market in APAC 2015-2020 ($ billions)
  • Exhibit 35: Pharmaceutical contract manufacturing market in EMEA 2015-2020 ($ billions)
  • Exhibit 36: Key leading countries
  • Exhibit 37: Impact of drivers and challenges on global pharmaceutical contract manufacturing market
  • Exhibit 38: Competitive advantage
  • Exhibit 39: Examples of global pharmaceutical companies sourcing from CMOs
  • Exhibit 40: Impact of drivers
  • Exhibit 41: Capacity constraints by stage production 2015
  • Exhibit 42: Impact of drivers and challenges
  • Exhibit 43: Impact of trends on global pharmaceutical contract manufacturing market
  • Exhibit 44: Major M&A in global pharmaceutical contract manufacturing market
  • Exhibit 45: Key vendors: Geographical presence 2015
  • Exhibit 46: Catalent: Profile
  • Exhibit 47: Catalent: Metrics analysis
  • Exhibit 48: Catalent: Growth strategy matrix
  • Exhibit 49: Catalent: Opportunity assessment
  • Exhibit 50: Lonza: Profile
  • Exhibit 51: Lonza: Metrics analysis
  • Exhibit 52: Lonza: Growth strategy matrix
  • Exhibit 53: Lonza: Opportunity assessment
  • Exhibit 54: Pfizer CentreOne: Profile
  • Exhibit 55: Pfizer CentreOne profile: Metrics analysis
  • Exhibit 56: Pfizer CentreOne: Growth strategy matrix
  • Exhibit 57: Pfizer CentreOne: Growth opportunity assessment
Back to Top